It is possible cMet interacts with other known oncogenic pathways in the development of, and chemotherapy resistance seen in CRC Yoon et al confirmed strong correlation between cMet and a related downstream nonreceptor tyrosine kinase, focal adhesion kinase (FAK) expression Hscores in CRC TMA. The gene discussed is MET; the disease is colorectal carcinoma.